SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (6731)5/12/1999 4:16:00 PM
From: VLAD  Read Replies (1) | Respond to of 7041
 
I'm a little disappointed. I thought it would be a little weaker towards close. Now look what has happened: It closed last Friday at $19.81 before the news and today it traded as high as $15.25 which is a 60% retracement from the trading low of $8.75 on Monday morning. That's a damned healthy bounce considering how bad the news was on Monday. I'm kind of expecting a slow bleed down from here as the reality of the situation sets in and new short positions are established. I just don't see any value here at these prices. Who would pay over 13 bucks for Zonagen considering current fundamentals. This companies ONLY product just got REJECTED by the FDA. HELLO!



To: Linda Kaplan who wrote (6731)5/12/1999 4:23:00 PM
From: VLAD  Read Replies (1) | Respond to of 7041
 
The short position was 2,461,753 as of 4-15. I believe that the majority of this short position that wanted out is out by now. Who's buying now at 13 5/8 (off by about 6 points now since before the bad news) when Zonagen has nothing to hype or spin for the rest of the year except progress on Vasofem which is a bunch of bs?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News